The Power of Industry in Medicine is tremendous, and the COST of speaking Truth to Power is real.
This is one example of how industry attempts to influence the narrative within medicine. @WesternTrauma
@prytimemedical - is the largest suppliers of REBOA catheter in the U.S.
🧵
Dave Spencer, @prytimemedical CEO says in a letter put out on March 3rd that one of the “fundamental Core Values is transparency and open communication” at Prytime Medical.
Yet he privately sends a scathing letter emailed to @WesternTrauma Officers and Board of Directors: 👇
This is based on a study that was done where the following abstract was submitted and accepted to @WesternTrauma:
"The Undisclosed Disclosures: The Dollar-Outcome Relationship in Resuscitative Endovascular Balloon Occlusion of the Aorta in Trauma"
The @WesternTrauma program committee, which is compiled of numerous clinicians and researchers from all across the country accepted the abstract for presentation:
Now lets be clear about a few things:
✅ The relationship between clinicians and industry can be incredibly valuable
✅ I personally have no issue of educational or research type collaborations, and clinicians should be valued for the time they Invest
As background the goal of the Physician Payment Sunshine Act is to:
✅Improve transparency from industry to physicians
✅Mandates disclosures of all ‘payments’ or ‘transfers of value’
This study by @TopKniFe_B and team looked at the relationship between physicians and the #REBOA industry evaluating Conflict of Interest (COI) disclosures.
The authors did a study that ANYONE can replicate because it’s all open access.
The definition of Inaccurate COI disclosure is: If at least 1 author received payment and did not report in the published study.
Results of Study:
◼️Accuracy of COI disclosures in REBOA studies is very low: 12%
◼️Articles with authors receiving payment were approximately 2X more likely to be FAVORABLE
This study, which is going to be presented on Tuesday March 7th @WesternTrauma continues to contribute to the literature about the opportunities we have to recognize our own bias and do better for patients.
Unfortunately, this is not where the story ends.........
A few summary thoughts:
1. The letter makes assumptions without even hearing the presentation.
2. This is not the first study demonstrating the COI inaccuracies.
3. This data is all open access and can be easily replicated if @prytimemedical wants to dispute the findings.
4. To send an email to @WesternTrauma Officers and the Board exerting their Influence on an evidenced based study that was accepted by the program committee is absolutely unacceptable.
5. This study highlights an opportunity for us to recognize the bias that exists in medicine.
6. The fact that @prytimemedical thinks the medical organization has to give PRIOR NOTICE to the company about a scientific presentation at their @AmCollSurgeons CME event is hogwash.
7. The @prytimemedical CEO implies that because they have been “dutiful partners over 10 years” they should receive some sort of special privilege and advanced warning about a scientific presentation!!?
I suspect if findings were favorable the same would not be true.
8. Dave Spencer clearly didn’t understand the study. It has nothing to do with what the company reported, it is about disclosure of payments by physicians and this is actually not a direct attack on the company.
9. This is an example of how a BILLION dollar industry exerts influence when it doesn’t necessarily align with their interest.
10. I’m disgusted by this "hit piece" against both a credible organization and credible authors that are respected trauma researchers.
What I want to see is how @WesternTrauma is going to respond to this.
We must not be bullied by powerful corporations. I hope you publicly respond to @prytimemedical & that you RECORD and display the presentation so there is no confusion about what is presented. #MedTwitter
No one wakes up expecting to be injured or have a surgical emergency, but I suspect most Americans expect to be taken care of.
Right now across America, healthcare workers are unable to treat patients with treatable disease. This is an absolute tragedy and preventable.
🧵
As a surgeon and critical care doctor, I have seen firsthand the inability for us to provide the support that we have for so many years to facilities that simply don’t have the resources to care for certain conditions.
Why?
It's not a lack of interest amoung HCWs, it’s simply a lack of beds.
The unwillingness for Americans to #GetVaccinated is of course putting their lives at risk, and now it is also preventing Americans with treatable diseases NOT to be treated. 🤯
As a surgeon who does both elective and emergency surgery, what’s happening again and now in hospitals across America is an atrocity.
🧵
Last year those of us who perform elective surgery pushed for conservation of resources. Whether that’s the appropriate utilization of nurses and surgeons or beds and ventilators. This allocation was critical in order to SAVE lives.
This of course came at a significant cost to healthcare systems that utilize the revenue from surgeries to ensure the ability of operationalizing other Departments in the hospital.
Surgery is mission critical for sustainability & delivery of care to communities across America.
And perhaps even more striking is that 30% don’t plan on being vaccinated or are yet to decide!
Health Inequity continues to be prevalent with only 39% of Black HCWs compared to 57% of White HCWs having received 1st dose. @DanielEDawes@EbonyJHilton_MD
Lots of noise about the safety + efficacy + trust of an expedited #vaccine this Fall. As a recent @RWJF Health Policy Fellow in the @USSenate, I had the opportunity to work on the SAVE Act. Some thoughts:
(1/10)
The Safe Authorization of Vaccines during Emergencies (SAVE) Act seeks to ensure that expedited delivery of a #vaccine (which we ALL want) is grounded in data & science. We cannot afford a bad vaccine—or further loss of public trust in a good vaccine—because of politics.
(2/10)
In drafting the bill, the primary goal was to ensure that officials within the Trump Administration could not circumvent the normal licensure process in which independent panels of experts vet and validate vaccine manufacturers data on the vaccine product.
(3/10)